Vanguard Group Inc Personalis, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Personalis, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,970,597 shares of PSNL stock, worth $11.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,970,597

Previous 1,904,165 3.49%

Holding current value

$11.3 Million

Previous $2.23 Million 376.02%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.19 - $6.34 $79,054 - $421,178	66,432 Added 3.49%	1,970,597 $10.6 Million
Q1 2024 May 10, 2024	SELL	$1.15 - $2.19 $190,818 - $363,384	-165,929 Reduced 8.02%	1,904,165 $2.84 Million
Q4 2023 Feb 14, 2024	BUY	$0.93 - $2.35 $4,178 - $10,558	4,493 Added 0.22%	2,070,094 $4.35 Million
Q1 2023 May 15, 2023	BUY	$2.01 - $4.17 $61,508 - $127,606	30,601 Added 1.5%	2,065,601 $5.7 Million
Q4 2022 Feb 10, 2023	SELL	$1.78 - $3.64 $51,420 - $105,152	-28,888 Reduced 1.4%	2,035,000 $4.03 Million
Q3 2022 Nov 14, 2022	BUY	$2.89 - $5.32 $760,679 - $1.4 Million	263,211 Added 14.62%	2,063,888 $6.13 Million
Q2 2022 Aug 12, 2022	SELL	$3.27 - $8.76 $833,820 - $2.23 Million	-254,991 Reduced 12.4%	1,800,677 $6.21 Million
Q1 2022 May 13, 2022	SELL	$7.56 - $14.3 $142,543 - $269,626	-18,855 Reduced 0.91%	2,055,668 $16.8 Million
Q4 2021 Feb 14, 2022	BUY	$12.24 - $21.25 $1.72 Million - $2.98 Million	140,123 Added 7.24%	2,074,523 $29.6 Million
Q3 2021 Nov 12, 2021	BUY	$16.69 - $26.05 $1.94 Million - $3.02 Million	116,022 Added 6.38%	1,934,400 $37.2 Million
Q2 2021 Aug 13, 2021	BUY	$18.15 - $27.75 $33 Million - $50.5 Million	1,818,378 New	1,818,378 $46 Million

Others Institutions Holding PSNL

# of Institutions

Shares Held

30.1M

Call Options Held

27.5K

Put Options Held

85.4K

View Full List

About Personalis, Inc.

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $264M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

More about PSNL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Personalis, Inc. Transaction History